Journal of the National Cancer Institute Advance Access originally published online on December 25, 2007
JNCI Journal of the National Cancer Institute 2008 100(1):1; doi:10.1093/jnci/djm322
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2007.
MEMO TO THE MEDIA |
Chemotherapy and Tamoxifen Reduce Risk of Second Breast Cancer
jncimedia@oxfordjournals.org
301-841-1287
| The first 10% of the full text of this article appears below. |
Among breast cancer patients, both chemotherapy and tamoxifen independently reduced the risk of developing a second cancer in the other breast, according to a study published online December 25 in the Journal of the National Cancer Institute. The risk reduction persisted for at least
Contact:
Citation:
Note to Reporters:
Related Article in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2008 100: 32-40.